SlideShare una empresa de Scribd logo
1 de 10
Descargar para leer sin conexión
FDA’s advice on
Acetaminophen (Paracetamol)
associated Serious skin reactions
P. Naina Mohamed
Pharmacologist
Introduction
 FDA notified healthcare professionals and patients that
acetaminophen has been associated with a risk of rare but serious
skin reactions.
 Paracetamol is a common active ingredient to treat pain and reduce
fever.
 It is included in many prescription and over-the-counter (OTC)
products.
 The skin reactions induced by Paracetamol includes Stevens-
Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and
acute generalized exanthematous pustulosis (AGEP) which can be
fatal.
 These reactions can occur with first-time use of acetaminophen or at
any time while it is being taken.
 Other drugs used to treat fever and pain/body aches (e.g., NSAIDS,
such as ibuprofen and naproxen) also carry the risk of causing
serious skin reactions, which is already described in the warnings
section of their drug labels.
Introduction
 The symptoms of Skin reactions induced by Paracetamol include rash,
blisters and, in the worst case, widespread damage to the surface of skin.
 Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are
the two most serious skin reactions linked in rare cases to acetaminophen.
They usually require hospitalization and can cause death.
 Problems usually begin with flu-like symptoms followed by rash, blistering
and extensive damage to the surfaces of the skin. Recovery can take weeks
or months, and possible complications include scarring, changes in skin
pigmentation, blindness and damage to internal organs.
 Acute generalized exanthematous pustulosis (AGEP), usually resolves
within two weeks of stopping the medication that caused the problem.
 A serious skin reaction can occur at any time, even if you've taken
acetaminophen previously without a problem. There is currently no way of
predicting who might be at higher risk.
 Patients should stop taking the product immediately when they develop a
rash or other skin reaction and seek medical attention right away.
 If patients ever had a skin reaction when taking acetaminophen, they should
not take the drug again and discuss alternate pain relievers/fever reducers
with the health care professional.
Mechanism of development of Fever
Infectious or Aseptic stimuli
Leukocytes
Endogenous pyrogens (Pyrogenic cytokines, such as interleukin- 1b (IL-1b), tumor necrosis factor
(TNF), and interleukin-6 (IL-6))
Elevation of prostaglandin E (PGE) in the cerebrospinal fluid
Elevated PGE acts on the Preoptic area of the anterior hypothalamus (POAH)
Alter the firing rate of neurons that control thermoregulation in the hypothalamus
Increase in the hypothalamic set point of body temperature
Enhanced release of thyroid hormones, glucocorticoids, and catecholamines
Cutaneous vasoconstriction, shivering, and nonshivering thermogenesis
Reduction of heat loss and increased heat gain
Fever
Mechanism of action of Paracetamol
Paracetamol (Acetaminophen)
Penetrates the blood-brain barrier
Blocks Cycloxygenase (COX3) in brain
Blocks the formation and release of prostaglandins (PGE) in the
central nervous system
Inhibit the action of endogenous pyrogens on the heat-regulating
centers in the brain
Antipyretic effect
Mechanism of action of Paracetamol
(Other Mechanisms)
Antipyretics
Diminished leukocyte-endothelial cell interactions,
Reduced pyrogenic cytokine production,
Enhanced expression of anti-inflammatory molecules,
Boosting the activity of endogenous antipyretic
messengers
Suppress tissue inflammation
Hypersensitivity reactions
Paracetamol
Inhibits cyclooxygenase (COX)-3 & COX 1
Reduced formation of PGE2
Decreased inhibition of 5- Lipoxygenase enzyme
Increased prodution of Cysteinyl Leukotrienes from
Arachidonic acid
Hypersensitivity reactions
Hypersensitivity reactions
(Other Mechanism)
Paracetamol
IgE mediated immune mechanisms
Hypersensitivity reactions
Conclusion
 Health care professionals should be aware of this rare risk of
paracetamol induced serious skin reactions.
 Any patient who develops a skin rash or reaction while using
paracetamol or any other pain reliever/fever reducer should stop the
drug and seek medical attention right away.
 Anyone who has experienced a serious skin reaction with paracetamol
should not take the drug again and should contact their health care
professional to discuss alternative pain relievers/fever reducers.
 FDA will require that a warning be added to the labels of prescription
drug products containing paracetamol to address the risk of serious
skin reactions.
 FDA will also request that manufacturers add a warning about serious
skin reactions to the product labels of OTC paracetamol drug products
marketed under a new drug application and will encourage
manufacturers of drug products marketed under the OTC monograph
do the same.
References
 http://www.fda.gov/Safety/MedWatch/SafetyInformation/
SafetyAlertsforHumanMedicalProducts/ucm363519.htm?
source=govdelivery
 http://www.fda.gov/ForConsumers/ConsumerUpdates/uc
m363010.htm?source=govdelivery
 http://www.ncbi.nlm.nih.gov/pubmed/22555261
 http://www.scai.cl/sites/default/files/Bibliografia%20Suge
rida%20Hipersensibilidad%20a%20paracetamol.pdf
 http://www.aacijournal.com/content/3/1/24
 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1113161/
 http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%2
0Documents/Practice%20and%20Parameters/drug-
allergy-updated-practice-param.pdf

Más contenido relacionado

La actualidad más candente (20)

Diuretics
DiureticsDiuretics
Diuretics
 
Prostaglandins pharmacology
Prostaglandins pharmacologyProstaglandins pharmacology
Prostaglandins pharmacology
 
Fibrinolytics
FibrinolyticsFibrinolytics
Fibrinolytics
 
Diuretics in hypertension 2015 by Dr Abhishek Rathore
Diuretics in hypertension 2015 by Dr Abhishek RathoreDiuretics in hypertension 2015 by Dr Abhishek Rathore
Diuretics in hypertension 2015 by Dr Abhishek Rathore
 
Antihistamines - Pharmacology
Antihistamines - PharmacologyAntihistamines - Pharmacology
Antihistamines - Pharmacology
 
5 ht
5 ht5 ht
5 ht
 
endocrine drugs pharmacology
endocrine drugs pharmacologyendocrine drugs pharmacology
endocrine drugs pharmacology
 
Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology
 
Histamines and antihistamine pharmacology
Histamines and antihistamine pharmacologyHistamines and antihistamine pharmacology
Histamines and antihistamine pharmacology
 
Thyroid & antithyroid drug
Thyroid & antithyroid drugThyroid & antithyroid drug
Thyroid & antithyroid drug
 
Insulin preparations
Insulin preparationsInsulin preparations
Insulin preparations
 
Levodopa+carbidopa
Levodopa+carbidopaLevodopa+carbidopa
Levodopa+carbidopa
 
Sympathomimetic
SympathomimeticSympathomimetic
Sympathomimetic
 
ACE Inhibitors
ACE InhibitorsACE Inhibitors
ACE Inhibitors
 
physiological role of prostaglandin
physiological role of prostaglandinphysiological role of prostaglandin
physiological role of prostaglandin
 
Sympatholytics
SympatholyticsSympatholytics
Sympatholytics
 
Anterior pituitary hormone analogues & inhibitors
Anterior pituitary hormone analogues & inhibitorsAnterior pituitary hormone analogues & inhibitors
Anterior pituitary hormone analogues & inhibitors
 
Histamine and antihistaminics
Histamine and antihistaminicsHistamine and antihistaminics
Histamine and antihistaminics
 
Anti diuretics drugs
Anti diuretics drugsAnti diuretics drugs
Anti diuretics drugs
 
Anti thyroid drugs
Anti thyroid drugsAnti thyroid drugs
Anti thyroid drugs
 

Similar a FDA's advice on_acetaminophen_(paracetamol)_associated serious skin reactions

Analgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptx
Analgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptxAnalgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptx
Analgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptxNtsoaki6
 
Class adverse drug reaction
Class adverse drug reactionClass adverse drug reaction
Class adverse drug reactionRaghu Prasada
 
Methylprednisolone Acetate Injectable suspension USP Taj Pharma PIL
Methylprednisolone Acetate Injectable suspension USP Taj Pharma PILMethylprednisolone Acetate Injectable suspension USP Taj Pharma PIL
Methylprednisolone Acetate Injectable suspension USP Taj Pharma PILTajPharmaQC
 
Meds For Pain And Inflammation
Meds For Pain And InflammationMeds For Pain And Inflammation
Meds For Pain And Inflammationpmrjulio
 
Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs Akshay Kumar
 
classantihistaminics.pptx
classantihistaminics.pptxclassantihistaminics.pptx
classantihistaminics.pptxssuser8705f6
 
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)Sohail Ahmad
 
Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )EL Sayed Sabry
 

Similar a FDA's advice on_acetaminophen_(paracetamol)_associated serious skin reactions (20)

Analgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptx
Analgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptxAnalgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptx
Analgesics - Nonsteroidal Anti-inflammatory (NSAIDs).pptx
 
ADR.pptx
ADR.pptxADR.pptx
ADR.pptx
 
Class adverse drug reaction
Class adverse drug reactionClass adverse drug reaction
Class adverse drug reaction
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 
Methylprednisolone Acetate Injectable suspension USP Taj Pharma PIL
Methylprednisolone Acetate Injectable suspension USP Taj Pharma PILMethylprednisolone Acetate Injectable suspension USP Taj Pharma PIL
Methylprednisolone Acetate Injectable suspension USP Taj Pharma PIL
 
Steroid suraj
Steroid surajSteroid suraj
Steroid suraj
 
Meds For Pain And Inflammation
Meds For Pain And InflammationMeds For Pain And Inflammation
Meds For Pain And Inflammation
 
Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs
 
Postanesthetic care
Postanesthetic carePostanesthetic care
Postanesthetic care
 
classantihistaminics.pptx
classantihistaminics.pptxclassantihistaminics.pptx
classantihistaminics.pptx
 
BScN NSAIDs.pptx
BScN NSAIDs.pptxBScN NSAIDs.pptx
BScN NSAIDs.pptx
 
NSAIDS.
NSAIDS.NSAIDS.
NSAIDS.
 
Cox inhibitor
Cox inhibitorCox inhibitor
Cox inhibitor
 
1.c.1 adverse drug reaction
1.c.1 adverse drug reaction1.c.1 adverse drug reaction
1.c.1 adverse drug reaction
 
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
 
Ocular Anti allergy drugs
Ocular Anti allergy drugsOcular Anti allergy drugs
Ocular Anti allergy drugs
 
Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )
 
Nsaids
NsaidsNsaids
Nsaids
 
Paracetamol
ParacetamolParacetamol
Paracetamol
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 

Más de Naina Mohamed, PhD

Drug interactions of Metformin
Drug interactions of MetforminDrug interactions of Metformin
Drug interactions of MetforminNaina Mohamed, PhD
 
Drug Interactions of Vorapaxar
Drug Interactions of VorapaxarDrug Interactions of Vorapaxar
Drug Interactions of VorapaxarNaina Mohamed, PhD
 
Drug interactions of Cilostazol
Drug interactions of CilostazolDrug interactions of Cilostazol
Drug interactions of CilostazolNaina Mohamed, PhD
 
Drug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitorsDrug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitorsNaina Mohamed, PhD
 
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Naina Mohamed, PhD
 
Drug Interactions of ADP receptor Blockers (Antiplatelets)
 Drug Interactions of ADP receptor Blockers (Antiplatelets) Drug Interactions of ADP receptor Blockers (Antiplatelets)
Drug Interactions of ADP receptor Blockers (Antiplatelets)Naina Mohamed, PhD
 
Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)Naina Mohamed, PhD
 
Fasting associated adverse effects
Fasting associated adverse effects Fasting associated adverse effects
Fasting associated adverse effects Naina Mohamed, PhD
 
Clinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of FibrinolyticsClinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of FibrinolyticsNaina Mohamed, PhD
 
Drug interactions of Urokinase
Drug interactions of UrokinaseDrug interactions of Urokinase
Drug interactions of UrokinaseNaina Mohamed, PhD
 
Drug Interactions of Streptokinase:
 Drug Interactions of Streptokinase: Drug Interactions of Streptokinase:
Drug Interactions of Streptokinase:Naina Mohamed, PhD
 
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Naina Mohamed, PhD
 
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Naina Mohamed, PhD
 
Complementary and alternative therapies for erectile dysfunction
Complementary and alternative  therapies for erectile dysfunctionComplementary and alternative  therapies for erectile dysfunction
Complementary and alternative therapies for erectile dysfunctionNaina Mohamed, PhD
 
Drug interactions of Dabigatran
Drug interactions of DabigatranDrug interactions of Dabigatran
Drug interactions of DabigatranNaina Mohamed, PhD
 
Drug interactions of Argatroban
Drug interactions of ArgatrobanDrug interactions of Argatroban
Drug interactions of ArgatrobanNaina Mohamed, PhD
 
Drug interactions of Heparinoids
Drug interactions of HeparinoidsDrug interactions of Heparinoids
Drug interactions of HeparinoidsNaina Mohamed, PhD
 
Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)Naina Mohamed, PhD
 

Más de Naina Mohamed, PhD (20)

Drug interactions of Metformin
Drug interactions of MetforminDrug interactions of Metformin
Drug interactions of Metformin
 
Drug Interactions of Vorapaxar
Drug Interactions of VorapaxarDrug Interactions of Vorapaxar
Drug Interactions of Vorapaxar
 
Drug interactions of Cilostazol
Drug interactions of CilostazolDrug interactions of Cilostazol
Drug interactions of Cilostazol
 
Drug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitorsDrug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitors
 
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
 
Drug Interactions of ADP receptor Blockers (Antiplatelets)
 Drug Interactions of ADP receptor Blockers (Antiplatelets) Drug Interactions of ADP receptor Blockers (Antiplatelets)
Drug Interactions of ADP receptor Blockers (Antiplatelets)
 
Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)
 
Fasting associated adverse effects
Fasting associated adverse effects Fasting associated adverse effects
Fasting associated adverse effects
 
Clinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of FibrinolyticsClinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of Fibrinolytics
 
Drug interactions of Urokinase
Drug interactions of UrokinaseDrug interactions of Urokinase
Drug interactions of Urokinase
 
Drug Interactions of Streptokinase:
 Drug Interactions of Streptokinase: Drug Interactions of Streptokinase:
Drug Interactions of Streptokinase:
 
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
 
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
 
Complementary and alternative therapies for erectile dysfunction
Complementary and alternative  therapies for erectile dysfunctionComplementary and alternative  therapies for erectile dysfunction
Complementary and alternative therapies for erectile dysfunction
 
Drug interactions of Dabigatran
Drug interactions of DabigatranDrug interactions of Dabigatran
Drug interactions of Dabigatran
 
Drug interactions of Argatroban
Drug interactions of ArgatrobanDrug interactions of Argatroban
Drug interactions of Argatroban
 
Drug interactions of Hirudins
Drug interactions of HirudinsDrug interactions of Hirudins
Drug interactions of Hirudins
 
Drug interactions of Heparinoids
Drug interactions of HeparinoidsDrug interactions of Heparinoids
Drug interactions of Heparinoids
 
Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)
 
Drug interactions of Heparin
Drug interactions of HeparinDrug interactions of Heparin
Drug interactions of Heparin
 

Último

Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational PhilosophyShuvankar Madhu
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17Celine George
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 

Último (20)

Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational Philosophy
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 

FDA's advice on_acetaminophen_(paracetamol)_associated serious skin reactions

  • 1. FDA’s advice on Acetaminophen (Paracetamol) associated Serious skin reactions P. Naina Mohamed Pharmacologist
  • 2. Introduction  FDA notified healthcare professionals and patients that acetaminophen has been associated with a risk of rare but serious skin reactions.  Paracetamol is a common active ingredient to treat pain and reduce fever.  It is included in many prescription and over-the-counter (OTC) products.  The skin reactions induced by Paracetamol includes Stevens- Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP) which can be fatal.  These reactions can occur with first-time use of acetaminophen or at any time while it is being taken.  Other drugs used to treat fever and pain/body aches (e.g., NSAIDS, such as ibuprofen and naproxen) also carry the risk of causing serious skin reactions, which is already described in the warnings section of their drug labels.
  • 3. Introduction  The symptoms of Skin reactions induced by Paracetamol include rash, blisters and, in the worst case, widespread damage to the surface of skin.  Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are the two most serious skin reactions linked in rare cases to acetaminophen. They usually require hospitalization and can cause death.  Problems usually begin with flu-like symptoms followed by rash, blistering and extensive damage to the surfaces of the skin. Recovery can take weeks or months, and possible complications include scarring, changes in skin pigmentation, blindness and damage to internal organs.  Acute generalized exanthematous pustulosis (AGEP), usually resolves within two weeks of stopping the medication that caused the problem.  A serious skin reaction can occur at any time, even if you've taken acetaminophen previously without a problem. There is currently no way of predicting who might be at higher risk.  Patients should stop taking the product immediately when they develop a rash or other skin reaction and seek medical attention right away.  If patients ever had a skin reaction when taking acetaminophen, they should not take the drug again and discuss alternate pain relievers/fever reducers with the health care professional.
  • 4. Mechanism of development of Fever Infectious or Aseptic stimuli Leukocytes Endogenous pyrogens (Pyrogenic cytokines, such as interleukin- 1b (IL-1b), tumor necrosis factor (TNF), and interleukin-6 (IL-6)) Elevation of prostaglandin E (PGE) in the cerebrospinal fluid Elevated PGE acts on the Preoptic area of the anterior hypothalamus (POAH) Alter the firing rate of neurons that control thermoregulation in the hypothalamus Increase in the hypothalamic set point of body temperature Enhanced release of thyroid hormones, glucocorticoids, and catecholamines Cutaneous vasoconstriction, shivering, and nonshivering thermogenesis Reduction of heat loss and increased heat gain Fever
  • 5. Mechanism of action of Paracetamol Paracetamol (Acetaminophen) Penetrates the blood-brain barrier Blocks Cycloxygenase (COX3) in brain Blocks the formation and release of prostaglandins (PGE) in the central nervous system Inhibit the action of endogenous pyrogens on the heat-regulating centers in the brain Antipyretic effect
  • 6. Mechanism of action of Paracetamol (Other Mechanisms) Antipyretics Diminished leukocyte-endothelial cell interactions, Reduced pyrogenic cytokine production, Enhanced expression of anti-inflammatory molecules, Boosting the activity of endogenous antipyretic messengers Suppress tissue inflammation
  • 7. Hypersensitivity reactions Paracetamol Inhibits cyclooxygenase (COX)-3 & COX 1 Reduced formation of PGE2 Decreased inhibition of 5- Lipoxygenase enzyme Increased prodution of Cysteinyl Leukotrienes from Arachidonic acid Hypersensitivity reactions
  • 8. Hypersensitivity reactions (Other Mechanism) Paracetamol IgE mediated immune mechanisms Hypersensitivity reactions
  • 9. Conclusion  Health care professionals should be aware of this rare risk of paracetamol induced serious skin reactions.  Any patient who develops a skin rash or reaction while using paracetamol or any other pain reliever/fever reducer should stop the drug and seek medical attention right away.  Anyone who has experienced a serious skin reaction with paracetamol should not take the drug again and should contact their health care professional to discuss alternative pain relievers/fever reducers.  FDA will require that a warning be added to the labels of prescription drug products containing paracetamol to address the risk of serious skin reactions.  FDA will also request that manufacturers add a warning about serious skin reactions to the product labels of OTC paracetamol drug products marketed under a new drug application and will encourage manufacturers of drug products marketed under the OTC monograph do the same.
  • 10. References  http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm363519.htm? source=govdelivery  http://www.fda.gov/ForConsumers/ConsumerUpdates/uc m363010.htm?source=govdelivery  http://www.ncbi.nlm.nih.gov/pubmed/22555261  http://www.scai.cl/sites/default/files/Bibliografia%20Suge rida%20Hipersensibilidad%20a%20paracetamol.pdf  http://www.aacijournal.com/content/3/1/24  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1113161/  http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%2 0Documents/Practice%20and%20Parameters/drug- allergy-updated-practice-param.pdf